+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Clobazam"

Grand Mal Seizure Treatment Global Market Report 2024 - Product Thumbnail Image

Grand Mal Seizure Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
From
Epilepsy Forecast and Market Analysis to 2035 - Product Thumbnail Image

Epilepsy Forecast and Market Analysis to 2035

  • Drug Pipelines
  • July 2019
  • 345 Pages
  • Global
From
From
The Treatment of Epilepsy. 3rd Edition - Product Thumbnail Image

The Treatment of Epilepsy. 3rd Edition

  • Book
  • July 2009
  • 1116 Pages
  • 10 Results (Page 1 of 1)
Loading Indicator

Clobazam is a benzodiazepine drug used to treat anxiety, seizures, and other conditions of the central nervous system. It is also used as an adjunct to other anticonvulsants in the treatment of epilepsy. Clobazam is a short-acting drug, meaning it has a rapid onset of action and a short duration of effect. It is metabolized in the liver and excreted in the urine. Clobazam is available in both generic and brand-name formulations. It is typically prescribed in tablet or liquid form, and is available in a variety of strengths. The drug is also available in combination with other anticonvulsants, such as phenytoin and valproic acid. The clobazam market is a competitive one, with a number of companies offering the drug. Some of the major players in the market include Pfizer, Novartis, Mylan, and Teva Pharmaceuticals. Other companies, such as Sun Pharmaceuticals, Lupin Pharmaceuticals, and Dr. Reddy's Laboratories, also offer clobazam products. Show Less Read more